{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:14:04Z","timestamp":1790745244748,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008810","name":"NSW Health Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bja.2019.02.024","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T11:10:48Z","timestamp":1554376248000},"page":"e135-e143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Integrating basophil activation tests into evaluation of perioperative anaphylaxis to neuromuscular blocking agents"],"prefix":"10.1016","volume":"123","author":[{"given":"Jamma","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver G.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suran L.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2019.02.024_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/bja\/aew251","article-title":"Perioperative anaphylaxis grading system: \u2018making the grade\u2019","volume":"117","author":"Rose","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.02.024_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11882-014-0452-6","article-title":"Perioperative anaphylaxis","volume":"14","author":"Galv\u00e3o","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.bja.2019.02.024_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.lpm.2016.02.024","article-title":"Epidemiology of perioperative anaphylaxis","volume":"45","author":"Mertes","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.bja.2019.02.024_bib4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/bja\/aes506","article-title":"Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011","volume":"110","author":"Sadleir","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.02.024_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0310057X1704500504","article-title":"Australian and New Zealand Anaesthetic Allergy Group perioperative anaphylaxis investigation guidelines","volume":"45","author":"Scolaro","year":"2017","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2019.02.024_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signalling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.bja.2019.02.024_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.12698","article-title":"The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease","volume":"70","author":"Hoffmann","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0310057X0002800207","article-title":"Immunoassays for the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects","volume":"28","author":"Fisher","year":"2000","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2019.02.024_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.anes.0000270735.40872.f2","article-title":"Immunoglobulin E antibodies to rocuronium","volume":"107","author":"Ebo","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2019.02.024_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/aas.13077","article-title":"Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolines","volume":"62","author":"Rose","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bja.2019.02.024_bib11","series-title":"Allergen c260 morphine","author":"Phadia ImmunoCAP","year":"2009"},{"key":"10.1016\/j.bja.2019.02.024_bib12","series-title":"Allergen c261 pholcodine","author":"ImmunoCAP","year":"2009"},{"key":"10.1016\/j.bja.2019.02.024_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, surgery and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.02.024_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/cyto.b.20526","article-title":"CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation","volume":"78","author":"Sturm","year":"2010","journal-title":"Cytom B Clin Cytom"},{"key":"10.1016\/j.bja.2019.02.024_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.bja.2019.02.024_bib16","series-title":"Antibiotic, Version 15","author":"Therapeutic Guidelines","year":"2014"},{"key":"10.1016\/j.bja.2019.02.024_bib17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1398-9995.2006.01094.x","article-title":"Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide","volume":"61","author":"Ebo","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1398-9995.2006.00978.x","article-title":"Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils","volume":"61","author":"Kvedariene","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1398-9995.2011.02569.x","article-title":"Allergy to rocuronium: from clinical suspicion to correct diagnosis","volume":"66","author":"Leysen","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/all.12468","article-title":"Flowcytometric diagnosis of atracurium-induced anaphylaxis","volume":"69","author":"Uyttebroek","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/17843286.2015.1122871","article-title":"Flow-assisted basophil activation tests in immediate drug hypersensitivity: two decades of Antwerp experience","volume":"71","author":"Mangodt","year":"2016","journal-title":"Acta Clin Belgica"},{"key":"10.1016\/j.bja.2019.02.024_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2044.2004.04086.x","article-title":"Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c","volume":"60","author":"Sudheer","year":"2005","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2019.02.024_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaip.2017.12.037","article-title":"Comparison of basophil activation test and skin testing performances in NMBA allergy","volume":"6","author":"Dewachter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.bja.2019.02.024_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/cea.12344","article-title":"Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need","volume":"44","author":"Leysen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1710-1492-9-42","article-title":"Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions","volume":"9","author":"Hagau","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.bja.2019.02.024_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0310057X1604400306","article-title":"Early skin and challenge testing after rocuronium anaphylaxis","volume":"44","author":"Schulberg","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2019.02.024_bib27","series-title":"Narcotic drugs 2015","author":"International Narcotics Control Board","year":"2016"},{"key":"10.1016\/j.bja.2019.02.024_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5415\/apallergy.2014.4.2.86","article-title":"Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan","volume":"4","author":"Katelaris","year":"2014","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1398-9995.2009.02193.x","article-title":"National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study","volume":"65","author":"Johansson","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.bja.2019.02.024_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/cyto.b.21003","article-title":"CD300a is expressed on human basophils and seems to inhibit IgE\/Fc\u03b5RI-dependent anaphylactic degranulation","volume":"82","author":"Sabato","year":"2012","journal-title":"Cytom B Clin Cytom"},{"key":"10.1016\/j.bja.2019.02.024_bib31","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.4049\/jimmunol.1500304","article-title":"The biology and disease relevance of CD300a, an inhibitory receptor for phosphatidylserine and phosphatidylethanolamine","volume":"194","author":"Zenarruzabeitia","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bja.2019.02.024_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cyto.a.23078","article-title":"Basophil activation test: implementation and standardization between systems and between instruments","volume":"91","author":"Depince-Berger","year":"2017","journal-title":"Cytometry A"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091219301606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091219301606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:55:06Z","timestamp":1757789706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091219301606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0007091219301606"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2019.02.024","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating basophil activation tests into evaluation of perioperative anaphylaxis to neuromuscular blocking agents","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2019.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}